Clinical Presentation and Evaluation of a Giant Lipomatous Tumor

Encountering a giant lipomatous tumor in the dorsal trunk presents substantial diagnostic, therapeutic, and reconstructive hurdles. Recently, clinicians reported the remarkable presentation of a 71-year-old male who developed a massive dorsal lesion over three decades. The lesion expanded at an accelerated pace during the previous two years, prompting specialized surgical consultation. Clinically, the thoracodorsal mass measured an astonishing 56 by 54 by 28 centimeters. Such massive lesions distort local musculoskeletal architecture and severely stretch the overlying cutaneous envelope. Furthermore, rapid growth after prolonged indolence strongly indicates potential malignant transformation or dedifferentiation. Soft tissue masses exceeding ten centimeters in mature adults routinely necessitate formal oncological evaluation. Therefore, clinicians must avoid dismissing chronic adipocytic swellings as harmless superficial lipomas without thorough investigations. In addition, excessive tumor weight profoundly impairs physical mobility, spinal alignment, and daily functional independence. Consequently, surgical teams must coordinate comprehensive cross-sectional imaging and histological testing without unnecessary delay. Early multidisciplinary evaluation prevents catastrophic diagnostic oversights and establishes safe therapeutic pathways.

Preoperative Imaging and Radiological Differentiation

Preoperative radiological imaging represents an indispensable component in assessing complex soft tissue neoplasms. Specifically, computed tomography and magnetic resonance imaging provide crucial insights regarding tissue composition and anatomical boundaries. In this landmark case, axial cross-sectional imaging revealed a predominantly fat-containing thoracodorsal mass measuring 27.1 by 18.6 centimeters. MRI highlighted distinctive internal architecture, including prominent fibrous septations and scattered solid nodules. However, the scans confirmed clear fat planes between the lesion and deeper musculature, ruling out overt chest wall invasion. These specific radiological hallmarks carry immense diagnostic utility during clinical triage. Plain benign lipomas typically show homogenous fat attenuation and very thin, uniform internal septa. In contrast, atypical lipomatous tumors consistently demonstrate irregular, thick septa exceeding two millimeters. Moreover, solid contrast-enhancing nodular components reliably distinguish well-differentiated liposarcomas from classic indolent lipomas. Advanced cross-sectional modalities also map key regional neurovascular structures with high fidelity. Thus, thorough radiological characterization dictates the feasibility of negative surgical margins before entering the operating theater.

Surgical Extirpation and Complex Soft Tissue Flap Reconstruction

Definitive surgical extirpation represents the primary therapeutic modality for giant trunk neoplasms. In this challenging case, the operative team performed complete en bloc surgical excision under general anesthesia. The resected surgical specimen demonstrated an astonishing final weight of ten kilograms. Furthermore, executing en bloc extirpation of this magnitude requires rigorous preservation of major vascular structures. However, resecting a ten-kilogram dorsal lesion invariably leaves a massive anatomical cavity and extensive skin deficiency. Consequently, reconstructive surgeons designed and mobilized large local cutaneous advancement flaps to cover the exposed dorsal surface. Standard primary wound approximation rarely achieves durable closure across such cavernous operative fields. Reconstructive teams often utilize rotational fasciocutaneous flaps or regional skin rearrangements to restore torso contour. In addition, surgeons must eliminate dead space meticulously and place multi-channel closed-suction drains. These proactive interventions prevent postoperative complications such as seroma accumulation, secondary wound infections, or hematomas. As a result of thorough intraoperative hemostasis, the patient enjoyed an uneventful postoperative recovery.

Histopathological Analysis and MDM2 Genetic Markers

Comprehensive histopathological examination establishes the definitive diagnosis in difficult adipocytic lesions. In this case, microscopic evaluation revealed mature adipocytes exhibiting striking variations in overall cellular size. In addition, pathologists identified scattered hyperchromatic, atypical stromal cells alongside unmistakable multivacuolated lipoblasts. These pathognomonic histological features strongly supported the diagnosis of an atypical lipomatous tumor or well-differentiated liposarcoma. However, immunohistochemical staining for murine double minute 2 (MDM2) yielded unexpected negative results. Typically, amplification of the MDM2 and CDK4 genes on chromosome 12q characterizes over 95 percent of well-differentiated liposarcomas. Nevertheless, immunohistochemical analysis occasionally demonstrates false-negative staining due to technical nuances or focal antigen expression. Molecular cytogenetics, including fluorescence in situ hybridization, represents the gold standard for MDM2 confirmation, but technical barriers often restrict accessibility. Therefore, clinicians and pathologists must synthesize microscopic architecture, gross surgical characteristics, and the prolonged clinical timeline. Consequently, the tumor board endorsed the diagnosis of atypical lipomatous tumor to direct ongoing patient surveillance.

Prognostic Implications, Surveillance, and Dedifferentiation Risk

Anatomical localization heavily influences the overall clinical behavior and prognosis of well-differentiated liposarcomas. When these low-grade neoplasms arise within superficial trunk wall tissues or the extremities, oncologists designate them as atypical lipomatous tumors. Importantly, extremity and trunk lesions carry virtually zero metastatic potential unless they undergo dedifferentiation. In stark contrast, retroperitoneal or mediastinal counterparts demonstrate recurrent behavior and significant disease-related mortality. Furthermore, long-standing or recurrent atypical lipomatous tumors face an approximate ten percent lifetime risk of dedifferentiating into high-grade sarcomas. Dedifferentiated liposarcomas exhibit aggressive invasiveness, increased metastatic rates, and poor survival statistics. Fortunately, complete macroscopic surgical resection with negative margins offers outstanding long-term local control for trunk lesions. In this reported clinical case, the patient remained entirely disease-free with no signs of recurrence at nine months. Nevertheless, oncologists recommend vigilant surveillance protocols spanning a minimum of five to ten years. Regular physical palpation, chest radiographs, and targeted magnetic resonance scans detect subtle recurrences early. Consequently, disciplined post-resection follow-up ensures prompt surgical intervention if local tumor regrowth ever emerges.

Frequently Asked Questions

How does an atypical lipomatous tumor differ from a benign lipoma?

Atypical lipomatous tumors share morphological similarities with benign lipomas but display distinct clinical and microscopic characteristics. While benign lipomas contain uniform mature adipocytes without cellular atypia, atypical lipomatous tumors show hyperchromatic stromal cells and lipoblasts. Radiologically, these atypical lesions often exceed five centimeters, demonstrate thick internal septa, and exhibit solid contrast-enhancing nodules on magnetic resonance imaging. Furthermore, atypical tumors possess recurrent potential and warrant vigilant long-term surveillance.

Why can MDM2 immunohistochemistry yield negative results in liposarcoma?

Although MDM2 gene amplification represents a genetic hallmark of well-differentiated liposarcoma, immunohistochemistry can occasionally yield false-negative outcomes. Technical factors, such as suboptimal tissue fixation, antigen masking, or focal marker expression, frequently account for negative antibody staining. In addition, biopsy sampling error may capture areas with low cell density. Consequently, fluorescence in situ hybridization serves as the definitive reference standard, while clinicians rely on careful clinicopathological correlation when molecular testing is unavailable.

What is the recommended follow-up protocol after complete tumor excision?

Following complete surgical resection of an atypical lipomatous tumor, guidelines recommend clinical surveillance every three to six months for the first two years. Thereafter, surveillance continues every six to twelve months for up to ten years. Physical examination evaluates the surgical scar for palpable nodules, while periodic magnetic resonance imaging detects asymptomatic deep recurrences. Extended surveillance remains vital because local recurrences can develop many years later and carry risks of high-grade dedifferentiation.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Zhang Z et al. Giant lipomatous tumor of the left back favoring atypical lipomatous tumor/well-differentiated liposarcoma: a case report. J Surg Case Rep. 2026 Sep undefined. doi: 10.1093/jscr/rjag707. PMID: 42798448.


2. WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2020.


3. von Mehren M, Kane JM, Agulnik M, et al. Soft Tissue Sarcoma, Version 1.2025, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2025;23(2):1-20.